Growth Metrics

Evolent Health (EVH) Income towards Parent Company (2016 - 2025)

Evolent Health has reported Income towards Parent Company over the past 12 years, most recently at -$429.2 million for Q4 2025.

  • Quarterly results put Income towards Parent Company at -$429.2 million for Q4 2025, down 1780.37% from a year ago — trailing twelve months through Dec 2025 was -$534.6 million (down 766.68% YoY), and the annual figure for FY2025 was -$534.5 million, changed.
  • Income towards Parent Company for Q4 2025 was -$429.2 million at Evolent Health, down from -$20.9 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for EVH hit a ceiling of $1.6 million in Q2 2024 and a floor of -$429.2 million in Q4 2025.
  • Median Income towards Parent Company over the past 5 years was -$20.0 million (2023), compared with a mean of -$52.0 million.
  • Biggest five-year swings in Income towards Parent Company: skyrocketed 621.89% in 2021 and later crashed 1780.37% in 2025.
  • Evolent Health's Income towards Parent Company stood at -$8.7 million in 2021, then soared by 94.68% to -$463000.0 in 2022, then crashed by 4215.77% to -$20.0 million in 2023, then decreased by 14.22% to -$22.8 million in 2024, then crashed by 1780.37% to -$429.2 million in 2025.
  • The last three reported values for Income towards Parent Company were -$429.2 million (Q4 2025), -$20.9 million (Q3 2025), and -$19.9 million (Q2 2025) per Business Quant data.